Taking into account the specificity we see of ANXA2 overexpression in ER-negative breast cancer and the potential influence ANXA2 has on disease progression in terms of lymph node involvement, we then wanted to ascertain the effect ANXA2 expression has on prognosis for breast cancer patients. Here, ANXA2 is linked to breast cancer.